Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant
- PMID: 36589219
- PMCID: PMC9773225
- DOI: 10.35772/ghm.2022.01069
Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant
Abstract
Although Omicron appears to cause less severe acute illness than the original strain, the potential for large numbers of patients to experience long COVID is a major concern. Little is known about the recovery phase in cases of Omicron, highlighting the importance of dynamically monitor long COVID in those patients. Subjects of the current study were patients available for a three-month follow-up who were admitted from January 13 to May 22, 2020 (period of the original strain) and from January 1 to May 30, 2022 (period of Omicron). Twenty-eight-point-four percent of patients infected with the original strain had long-term symptoms of COVID-19 and 5.63% of those infected with the Omicron strain had such symptoms. The most common symptom was a cough (18.5%), followed by tightness in the chest (6.5%), in patients infected with the original strain. Fatigue (2.4%) and dyspnea (1.7%) were the most commonly reported symptoms in patients infected with the Omicron strain. The respiratory system is the primary target of SARSCoV-2. Supportive treatment is the basis for the treatment of respiratory symptoms in patients with COVID-19. Quality sleep and good nutrition may alleviate fatigue and mental issues. Further knowledge about a long-term syndrome due to Omicron needs to be discussed and assembled so that healthcare and workforce planners can rapidly obtain information to appropriately allocate resources.
Keywords: Omicron variant; SARS-CoV-2; long COVID; long-term sequelae.
2022, National Center for Global Health and Medicine.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Nov 30;19(23):16010. doi: 10.3390/ijerph192316010. Int J Environ Res Public Health. 2022. PMID: 36498103 Free PMC article. Review.
-
Clinical and Pulmonary CT Characteristics of Patients Infected With the SARS-CoV-2 Omicron Variant Compared With Those of Patients Infected With the Alpha Viral Strain.Front Public Health. 2022 Jul 12;10:931480. doi: 10.3389/fpubh.2022.931480. eCollection 2022. Front Public Health. 2022. PMID: 35903393 Free PMC article.
-
The Burden and Characteristics of Post-COVID-19 Conditions Among Laboratory-Confirmed Delta and Omicron COVID-19 Cases: A Preliminary Study From Maharashtra, India.Cureus. 2023 Sep 8;15(9):e44888. doi: 10.7759/cureus.44888. eCollection 2023 Sep. Cureus. 2023. PMID: 37814744 Free PMC article.
-
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.medRxiv [Preprint]. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927. medRxiv. 2022. Update in: EBioMedicine. 2022 May;79:104008. doi: 10.1016/j.ebiom.2022.104008. PMID: 35118480 Free PMC article. Updated. Preprint.
-
COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.Tohoku J Exp Med. 2022 Sep 6;258(2):103-110. doi: 10.1620/tjem.2022.J067. Epub 2022 Aug 25. Tohoku J Exp Med. 2022. PMID: 36002251
Cited by
-
Long-term outcomes of SARS-CoV-2 variants and other respiratory infections: evidence from the Virus Watch prospective cohort in England.Epidemiol Infect. 2024 May 10;152:e77. doi: 10.1017/S0950268824000748. Epidemiol Infect. 2024. PMID: 38724258 Free PMC article.
-
Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID.Infect Chemother. 2024 Mar;56(1):122-157. doi: 10.3947/ic.2024.0024. Epub 2024 Mar 13. Infect Chemother. 2024. PMID: 38527781 Free PMC article. Review.
-
Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study.Sci Rep. 2024 Jan 9;14(1):854. doi: 10.1038/s41598-023-50024-4. Sci Rep. 2024. PMID: 38191556 Free PMC article.
-
Benefit of Nasal Douche in COVID-19 Patients with Recurrence of Positive SARS-CoV-2 Viral RNA.Infect Drug Resist. 2023 Sep 21;16:6269-6276. doi: 10.2147/IDR.S421380. eCollection 2023. Infect Drug Resist. 2023. PMID: 37750173 Free PMC article.
-
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.Viruses. 2023 Jul 7;15(7):1515. doi: 10.3390/v15071515. Viruses. 2023. PMID: 37515201 Free PMC article.
References
-
- WHO. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (accessed September 1, 2022).
LinkOut - more resources
Full Text Sources
Miscellaneous